Diagnostic value of contrast-enhanced transabdominal ultrasound and contrast-enhanced endoscopic ultrasound in pancreatic cystic tumors

Purpose: Pancreatic cystic tumors account for approximately 1 – 2% of pancreatic tumors. Contrast-enhanced ultrasound has now been used for the differential diagnosis of pancreatic cancer. This research aimed to investigate the diagnostic value of contrast-enhanced transabdominal ultrasound (CEUS) and contrast-enhanced endoscopic ultrasound (CE-EUS) in pancreatic cystic tumors. Material and methods: We prospectively reviewed database of patients diagnosed with pancreatic cystic tumors between April 2015 and October 2015 in our institute. The inclusion criteria were as follows: patients who underwent conventional…